BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34246743)

  • 1. Conjugation with nanodiamonds via hydrazone bond fundamentally alters intracellular distribution and activity of doxorubicin.
    Yuan SJ; Wang C; Xu HZ; Liu Y; Zheng MY; Li K; Sun SK; Komatsu N; Zhao L; Chen X
    Int J Pharm; 2021 Sep; 606():120872. PubMed ID: 34246743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
    Yuan SJ; Xu YH; Wang C; An HC; Xu HZ; Li K; Komatsu N; Zhao L; Chen X
    J Nanobiotechnology; 2019 Oct; 17(1):110. PubMed ID: 31623629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells.
    Xu HZ; Li TF; Wang C; Ma Y; Liu Y; Zheng MY; Liu ZJ; Chen JB; Li K; Sun SK; Komatsu N; Xu YH; Zhao L; Chen X
    J Nanobiotechnology; 2021 Sep; 19(1):268. PubMed ID: 34488792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy.
    Li TF; Xu YH; Li K; Wang C; Liu X; Yue Y; Chen Z; Yuan SJ; Wen Y; Zhang Q; Han M; Komatsu N; Zhao L; Chen X
    Acta Biomater; 2019 Mar; 86():381-394. PubMed ID: 30654213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes.
    Chen Z; Yuan SJ; Li K; Zhang Q; Li TF; An HC; Xu HZ; Yue Y; Han M; Xu YH; Komatsu N; Zhao L; Chen X
    J Control Release; 2020 Apr; 320():469-483. PubMed ID: 31987922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin conjugated with nanodiamonds and in free form commit glioblastoma cells to heterodromous fates.
    Chen Z; Wang C; Li TF; Li K; Yue Y; Liu X; Xu HZ; Wen Y; Zhang Q; Han M; Komatsu N; Xu YH; Zhao L; Chen X
    Nanomedicine (Lond); 2019 Feb; 14(3):335-351. PubMed ID: 30676239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.
    Li TF; Li K; Zhang Q; Wang C; Yue Y; Chen Z; Yuan SJ; Liu X; Wen Y; Han M; Komatsu N; Xu YH; Zhao L; Chen X
    Biomaterials; 2018 Oct; 181():35-52. PubMed ID: 30071380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells.
    Zhao L; Xu YH; Akasaka T; Abe S; Komatsu N; Watari F; Chen X
    Biomaterials; 2014 Jul; 35(20):5393-5406. PubMed ID: 24720879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets are highly efficient and efficacious carriers for tumor-targeted nano-drug delivery.
    Li QR; Xu HZ; Xiao RC; Liu Y; Tang JM; Li J; Yu TT; Liu B; Li LG; Wang MF; Han N; Xu YH; Wang C; Komatsu N; Zhao L; Peng XC; Li TF; Chen X
    Drug Deliv; 2022 Dec; 29(1):937-949. PubMed ID: 35319321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
    Xiong XB; Ma Z; Lai R; Lavasanifar A
    Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructose-Coated Nanodiamonds: Promising Platforms for Treatment of Human Breast Cancer.
    Zhao J; Lai H; Lu H; Barner-Kowollik C; Stenzel MH; Xiao P
    Biomacromolecules; 2016 Sep; 17(9):2946-55. PubMed ID: 27442218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.
    Pramod PS; Shah R; Jayakannan M
    Nanoscale; 2015 Apr; 7(15):6636-52. PubMed ID: 25797322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Triple Negative Breast Cancer Cells with Novel Cytotoxic Peptide-Doxorubicin Conjugates.
    Ziaei E; Saghaeidehkordi A; Dill C; Maslennikov I; Chen S; Kaur K
    Bioconjug Chem; 2019 Dec; 30(12):3098-3106. PubMed ID: 31715102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tumor-targeted, intracellular activatable and theranostic nanodiamond drug platform for strongly enhanced in vivo antitumor therapy.
    Du X; Li L; Wei S; Wang S; Li Y
    J Mater Chem B; 2020 Feb; 8(8):1660-1671. PubMed ID: 32011619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Uptake Behavior of Doxorubicin-Conjugated Nanodiamond Clusters for Efficient Cancer Therapy.
    Ryu TK; Lee GJ; Rhee CK; Choi SW
    Macromol Biosci; 2015 Oct; 15(10):1469-75. PubMed ID: 26097075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanodiamonds-mediated doxorubicin nuclear delivery to inhibit lung metastasis of breast cancer.
    Xiao J; Duan X; Yin Q; Zhang Z; Yu H; Li Y
    Biomaterials; 2013 Dec; 34(37):9648-56. PubMed ID: 24016858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.
    van Wijngaarden J; van Beek E; van Rossum G; van der Bent C; Hoekman K; van der Pluijm G; van der Pol MA; Broxterman HJ; van Hinsbergh VW; Löwik CW
    Eur J Cancer; 2007 Jan; 43(2):433-42. PubMed ID: 17097285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.